Weed killer: Bayer wins glyphosate trial – shares rise before market opens
The trial is the second one within a few months that Bayer has won in the glyphosate case. A verdict is still pending in another lawsuit. The case is worth billions for Bayer.
A US jury in Missouri has unanimously ruled in favour of Bayer in a glyphosate case. The trial was significant as the plaintiffs presented different arguments against the company, claiming that the weed killer Roundup was defectively designed and that they were intentionally misled. Bayer's stock price rose by around 4 percent on the Tradegate trading platform following the verdict.
The company has already won a landmark glyphosate case at the US Supreme Court, which has limited the scope for future lawsuits. Bayer is now awaiting a judge's decision on a proposed settlement, under which it would pay up to $7.25 billion over 21 years.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Technology Group: Microsoft starts strongly into the new fiscal year handelsblatt.com
